A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
Falini B, Martino G, Lazzi S.
Leukemia. 2023 Jan;37(1):18-34. doi: 10.1038/s41375-022-01764-1. Epub 2022 Dec 2.
CAR T-Cell Therapy in Hematological Malignancies.
Haslauer T, Greil R, Zaborsky N, Geisberger R.
Int J Mol Sci. 2021 Aug 20;22(16):8996. doi: 10.3390/ijms22168996.
Hematologic cancers in individuals infected by HIV.
Carbone A, Vaccher E, Gloghini A.
Blood. 2022 Feb 17;139(7):995-1012. doi: 10.1182/blood.2020005469.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d'Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD.
Blood. 2022 Sep 15;140(11):1229-1253. doi: 10.1182/blood.2022015851.
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.
Salles G, Barrett M, Foà R, Maurer J, O'Brien S, Valente N, Wenger M, Maloney DG.
Adv Ther. 2017 Oct;34(10):2232-2273. doi: 10.1007/s12325-017-0612-x. Epub 2017 Oct 5.
Therapeutic challenges in peripheral T-cell lymphoma.
Luan Y, Li X, Luan Y, Luo J, Dong Q, Ye S, Li Y, Li Y, Jia L, Yang J, Yang DH.
Mol Cancer. 2024 Jan 4;23(1):2. doi: 10.1186/s12943-023-01904-w.
CAR-T cell therapy for patients with hematological malignancies. A systematic review.
Pasqui DM, Latorraca CDOC, Pacheco RL, Riera R.
Eur J Haematol. 2022 Dec;109(6):601-618. doi: 10.1111/ejh.13851. Epub 2022 Sep 18.
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Lacy SE, Barrans SL, Beer PA, Painter D, Smith AG, Roman E, Cooke SL, Ruiz C, Glover P, Van Hoppe SJL, Webster N, Campbell PJ, Tooze RM, Patmore R, Burton C, Crouch S, Hodson DJ.
Blood. 2020 May 14;135(20):1759-1771. doi: 10.1182/blood.2019003535.
The nuclear export protein XPO1 - from biology to targeted therapy.
Azmi AS, Uddin MH, Mohammad RM.
Nat Rev Clin Oncol. 2021 Mar;18(3):152-169. doi: 10.1038/s41571-020-00442-4. Epub 2020 Nov 10.
Global burden of hematologic malignancies and evolution patterns over the past 30 years.
Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, Ma L, Liu X, Zhou F.
Blood Cancer J. 2023 May 17;13(1):82. doi: 10.1038/s41408-023-00853-3.
